Search research articles
Contact Us
Filters
Showing results (161-170 of 271) with videos related to
Page
of 28
Sort By:
Clinical Pharmacokinetics
|
July 1, 1993
Lomefloxacin clinical pharmacokinetics
C D Freeman, D P Nicolau, P P Belliveau, et al.
The Journal of Infectious Diseases
|
May 1, 1988
Pharmacokinetics of nafcillin in obesity
J Yuk, C H Nightingale, K Sweeney, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1992
Intraocular penetration of rifampin in humans
W R Outman, R E Levitz, D A Hill, et al.
Current Clinical Topics in Infectious Diseases
|
August 16, 2000
Cost-effectiveness in the use of antibiotics
J McNabb, R Quintiliani, D P Nicolau, et al.
American Journal of Hospital Pharmacy
|
January 1, 1984
Stability of tobramycin sulfate mixed with oxacillin sodium and nafcillin sodium in human serum
F S Lundergan, T P Lombardi, G E Neilan, et al.
American Journal of Hospital Pharmacy
|
June 1, 1981
Training hospital pharmacy technicians: joint effort by departments of education and pharmacy
G C Gousse, C B Crudi, J C Lylis, et al.
Antimicrobial Agents and Chemotherapy
|
September 3, 1999
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis
K Q Bui, J McNabb, C Li, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1996
Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections
D P Nicolau, C H Nightingale, M A Banevicius, et al.
The Journal of Antimicrobial Chemotherapy
|
August 2, 2001
Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam
M K Kim, D Xuan, R Quintiliani, et al.
International Journal of Antimicrobial Agents
|
June 9, 2001
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
D P Nicolau, J McNabb, M K Lacy, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 271) with videos related to
Sort By:
Page
of 28
Clinical Pharmacokinetics
|
July 1, 1993
Lomefloxacin clinical pharmacokinetics
C D Freeman, D P Nicolau, P P Belliveau, et al.
The Journal of Infectious Diseases
|
May 1, 1988
Pharmacokinetics of nafcillin in obesity
J Yuk, C H Nightingale, K Sweeney, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1992
Intraocular penetration of rifampin in humans
W R Outman, R E Levitz, D A Hill, et al.
Current Clinical Topics in Infectious Diseases
|
August 16, 2000
Cost-effectiveness in the use of antibiotics
J McNabb, R Quintiliani, D P Nicolau, et al.
American Journal of Hospital Pharmacy
|
January 1, 1984
Stability of tobramycin sulfate mixed with oxacillin sodium and nafcillin sodium in human serum
F S Lundergan, T P Lombardi, G E Neilan, et al.
American Journal of Hospital Pharmacy
|
June 1, 1981
Training hospital pharmacy technicians: joint effort by departments of education and pharmacy
G C Gousse, C B Crudi, J C Lylis, et al.
Antimicrobial Agents and Chemotherapy
|
September 3, 1999
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis
K Q Bui, J McNabb, C Li, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1996
Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections
D P Nicolau, C H Nightingale, M A Banevicius, et al.
The Journal of Antimicrobial Chemotherapy
|
August 2, 2001
Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam
M K Kim, D Xuan, R Quintiliani, et al.
International Journal of Antimicrobial Agents
|
June 9, 2001
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
D P Nicolau, J McNabb, M K Lacy, et al.
Page
of 28